These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Heterogeneous multi-laminar tissue constructs as a platform to evaluate aortic valve matrix-dependent pathogenicity. Monroe MN, Nikonowicz RC, Grande-Allen KJ. Acta Biomater; 2019 Oct 01; 97():420-427. PubMed ID: 31362141 [Abstract] [Full Text] [Related]
23. Increased Calcific Aortic Valve Disease in response to a diabetogenic, procalcific diet in the LDLr-/-ApoB100/100 mouse model. Scatena M, Jackson MF, Speer MY, Leaf EM, Wallingford MC, Giachelli CM. Cardiovasc Pathol; 2018 Oct 01; 34():28-37. PubMed ID: 29539583 [Abstract] [Full Text] [Related]
24. A Highly Predictive Risk Model for Pacemaker Implantation After TAVR. Maeno Y, Abramowitz Y, Kawamori H, Kazuno Y, Kubo S, Takahashi N, Mangat G, Okuyama K, Kashif M, Chakravarty T, Nakamura M, Cheng W, Friedman J, Berman D, Makkar RR, Jilaihawi H. JACC Cardiovasc Imaging; 2017 Oct 01; 10(10 Pt A):1139-1147. PubMed ID: 28412434 [Abstract] [Full Text] [Related]
26. Understanding the structural features of symptomatic calcific aortic valve stenosis: A broad-spectrum clinico-pathologic study in 236 consecutive surgical cases. Galli D, Manuguerra R, Monaco R, Manotti L, Goldoni M, Becchi G, Carubbi C, Vignali G, Cucurachi N, Gherli T, Nicolini F, Lorusso R, Vitale M, Corradi D. Int J Cardiol; 2017 Feb 01; 228():364-374. PubMed ID: 27866029 [Abstract] [Full Text] [Related]
27. Computed Tomography Score of Aortic Valve Tissue May Predict Cerebral Embolism During Transcatheter Aortic Valve Implantation. Tada N, Haga Y, Suzuki S, Enta Y, Miyasaka M, Inoue H, Taguri M, Ishii K, Hata M, Sakuma M, Toyoda S, Inoue T, Ootomo T. JACC Cardiovasc Imaging; 2017 Aug 01; 10(8):960-962. PubMed ID: 28797420 [No Abstract] [Full Text] [Related]
30. Impact of Aortomitral Continuity Calcification on Need for Permanent Pacemaker After Transcatheter Aortic Valve Replacement. Katchi F, Bhatt D, Markowitz SM, Szymonifka J, Cheng EP, Minutello RM, Bergman GW, Wong SC, Salemi A, Truong QA. Circ Cardiovasc Imaging; 2019 Dec 01; 12(12):e009570. PubMed ID: 31813271 [Abstract] [Full Text] [Related]
31. The progression of calcific aortic valve disease through injury, cell dysfunction, and disruptive biologic and physical force feedback loops. Li C, Xu S, Gotlieb AI. Cardiovasc Pathol; 2013 Dec 01; 22(1):1-8. PubMed ID: 22795219 [Abstract] [Full Text] [Related]
34. Impact of different aortic valve calcification patterns on the outcome of transcatheter aortic valve implantation: A finite element study. Sturla F, Ronzoni M, Vitali M, Dimasi A, Vismara R, Preston-Maher G, Burriesci G, Votta E, Redaelli A. J Biomech; 2016 Aug 16; 49(12):2520-30. PubMed ID: 27059259 [Abstract] [Full Text] [Related]
35. Histopathological assessment of calcification and inflammation of calcific aortic valves from patients with and without diabetes mellitus. Mosch J, Gleissner CA, Body S, Aikawa E. Histol Histopathol; 2017 Mar 16; 32(3):293-306. PubMed ID: 27353274 [Abstract] [Full Text] [Related]
36. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement. Yeghiazaryan K, Skowasch D, Bauriedel G, Schild H, Golubnitschaja O. Amino Acids; 2007 Jan 16; 32(1):109-14. PubMed ID: 16874466 [Abstract] [Full Text] [Related]